Eradication of Potential In-Transit Metastasis in Breast-Conserving Surgery-Reply

Jana de Boniface^{1

2}, Robert Szulkin^{3

4}, Anna L V Johansson^{4

5}

Affiliations

¹ Department of Surgery, Capio St Göran's Hospital, Stockholm, Sweden.
² Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
³ SDS Life Science, Danderyd, Sweden.
⁴ Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
⁵ Cancer Registry of Norway, Oslo, Norway.

Comment

Jana de Boniface et al. JAMA Surg. 2022.

. 2022 Feb 1;157(2):174-175.

doi: 10.1001/jamasurg.2021.5352.

Jana de Boniface^{1

2}, Robert Szulkin^{3

4}, Anna L V Johansson^{4

5}

¹ Department of Surgery, Capio St Göran's Hospital, Stockholm, Sweden.
² Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
³ SDS Life Science, Danderyd, Sweden.
⁴ Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
⁵ Cancer Registry of Norway, Oslo, Norway.

No abstract available

Comment on

Survival After Breast Conservation vs Mastectomy Adjusted for Comorbidity and Socioeconomic Status: A Swedish National 6-Year Follow-up of 48 986 Women.
de Boniface J, Szulkin R, Johansson ALV. de Boniface J, et al. JAMA Surg. 2021 Jul 1;156(7):628-637. doi: 10.1001/jamasurg.2021.1438. JAMA Surg. 2021. PMID: 33950173 Free PMC article.
Eradication of Potential In-Transit Metastasis in Breast-Conserving Surgery.
Lin X, Chen W, Wei F. Lin X, et al. JAMA Surg. 2022 Feb 1;157(2):174. doi: 10.1001/jamasurg.2021.5349. JAMA Surg. 2022. PMID: 34705047 No abstract available.